Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

COMPLETED

NCT07896993

Mask Instant Clinical Study

Sponsor: ChinaNorm

View on ClinicalTrials.gov

Summary

The goal of this clinical study is to evaluate the soothing effect of the test product within 2 hours after a single application by measuring changes in multiple indicators before and after product use. It will also assess the safety of the test product. The main questions it aims to answer are: * Does the test product relieve skin irritation and reduce skin redness within 2 hours after single use? * What adverse skin reactions do participants experience after using the test product? Researchers will compare the treated half-face with the untreated contralateral half-face (split-face control) to verify the soothing efficacy of the test product. Participants will: * Receive skin redness induction on both cheeks, then apply the test product on one side of the face * Undergo skin assessments at baseline before redness induction, post-induction, and at 10 seconds, 1 minute, 5 minutes, 10 minutes, 1 hour and 2 hours after product application * Complete clinical evaluation, instrumental measurement, image analysis and self-assessment questionnaires at each time point

Key Details

Gender

FEMALE

Age Range

25 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2026-06-12

Completion Date

2026-06-30

Last Updated

2026-10-27

Healthy Volunteers

Yes

Conditions

Skin Barrier Function Skin Soothing Effect

Interventions

OTHER

Test soothing facial mask

Facial mask containing panthenol and madecassoside, applied on one hemiface for 15 minutes in single use after erythema induction.

Inclusion Criteria: * 1\. Chinese female, 25-45 years old. 2. Self-declare mild sensitive skin. 3. Self-declare with skin concerns of redness and easy to flush. 4. Willing to be exposed to infrared light on the facial area to induce facial redness. 5\. Presenting with corresponding severity for the attribute evaluated by Dermatologist included: ◼ Skin redness after infrared light induction (7-8 min): grade ≥4 (0-9 scale). 6. All accept not to use any cosmetics, skincare products, beauty equipment, and all topical medications on the face within 72 hours prior to the study and on the visit day before coming to the lab, except for a cleanser. 7. Did not participate in any clinical test or cosmetic product test on skin within 1 month. 8\. No disagreement of dermatologist because of other reasons that exclude the participation of the volunteer. 9. In general, good health at the time of the study. 10. Willing and able to participate as evidenced by signing of informed consent and photo release form. 11\. Must be willing to comply with all study protocol requirements. Exclusion Criteria: * 1\. Pregnant or breast-feeding woman or woman planning pregnancy during the study. 2\. Subject deprived of rights by a court or administrative order. 3. Major subject to a guardianship order. 4. Subject residing in a health or social care establishment. 5. Patient in an emergency setting. 6. Volunteer with a skin disease in the test areas as well as skin allergy (particularly e.g., acne, rosacea, eczema). 7. Volunteer presenting a stable or progressive serious disease (per investigator's assessment). 8\. Immuno-compromised subject. 9. Subject with history of allergy to cosmetic or personal care products or ingredients. 10\. Subject presenting excessive exposure to sunlight or UV radiation (investigator's assessment). 11\. Subject with history of sunlight sensitivity or allergies. 12. Subjects regularly practicing aquatic or nautical sports. 13. Subjects regularly attending a sauna. 14. Subject with physical highly sensitive constitution. 15. Subject with cardiovascular or circulatory history. 16. Subject with a history of skin cancer or malignant melanoma. 17. Subject with history of medical beauty treatment and taking part in other studies in the last 6 months before study. 18.Use of antihistamines, antibiotics, corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), or immunosuppressants within 6 months prior to the study.

Locations (1)

Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072, Shanghai,

Shanghai, Shanghai Municipality, China